Careconnect Health Inc
Analysis
Careconnect Health Inc is a registered charity in United States, based in Richland, GA. It received its IRS tax-exemption ruling in January 1981, 45 years ago. The IRS classifies it as a supporting organisation under section 501(c)(3), and contributions to it are listed as tax-deductible.
In the financial year ending January 2024, Careconnect Health Inc reported income of $75.7m and spending of $66.3m, spending 88% of its income. Across the 5 years on record, from January 2020 to January 2024, income grew from $44.8m to $75.7m (+69%), an average of +14% a year. The sharpest change came in the year to January 2022, when income rose by 32%. Over the whole period it spent 80% of the income it received.
Among 72,936 United States charities whose main cause is other charitable purposes and that reported income, Careconnect Health Inc sits at the 99th percentile: it is one of the largest 1% in its cause. Against every charity in United States with reported income it ranks in the 99th percentile, and in the 99th percentile within GA. Charities of a similar size with the same main cause include Mymichigan Medical Center Clare ($75.6m), Independent Order of Odd Fellows ($75.8m) and Rediscover ($75.6m).
On its Form 990 for the period ending January 2024, revenue came from contributions and grants 18% and program service revenue 82% of the total. Compensation of current officers, directors and key employees was $1.3m (1.9% of expenses). Other salaries and wages came to $36.0m. At year end it held assets of $101.7m against liabilities of $10.6m, net assets of $91.1m. It reported 883 employees.
Income and spending
Where the income comes from
- Contributions & grants 18%
- Program services 82%
- Other 0.4%
Similar-sized charities, same cause
| Charity | Location | Income |
|---|---|---|
| Mymichigan Medical Center Clare | Midland | $75.6m |
| Independent Order of Odd Fellows | Saratoga | $75.8m |
| Rediscover | Lees Summit | $75.6m |
| Massachusetts Institute of Technology Welfare Benefit Plans T | Cambridge | $75.9m |